FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4223423433> ?p ?o ?g. }

• W4223423433 endingPage "162" @default.
• W4223423433 startingPage "152" @default.
• W4223423433 abstract "Long-chain fatty acid oxidation disorders (LC-FAOD) are a group of inborn errors of metabolism wherein patients are unable to process long-chain fatty acids into useable energy in the mitochondria. LC-FAOD commonly affects organ systems with high energy demand, manifesting as hypoketotic hypoglycemia, liver dysfunction, cardiomyopathy, rhabdomyolysis, and skeletal myopathy, as well as peripheral neuropathy and retinopathy in some subtypes. Collectively, LC-FAOD have a high mortality rate, especially in cases of early onset disease, and in the presence of cardiomyopathy. Triheptanoin is a synthetic medium-odd chain triglyceride, produced using a GMP-compliant process, which was designed to replenish mitochondrial metabolic deficits and restore energy homeostasis. Prior to its approval, triheptanoin was only available through clinical trials or to seriously ill patients as part of an expanded access program (EAP) following physician request. This retrospective study examined the impact of triheptanoin on cardiovascular parameters, in critically ill patients who participated in the EAP from February 2013 to January 2018. These patients persisted in critical condition despite receiving standard treatment in highly qualified centers by expert metabolic physicians and dietitians. Physician-completed questionnaires and narrative summaries were used to evaluate the disease presentation and management prior to the trigger event leading to triheptanoin request and use, and the response to triheptanoin treatment. Following triheptanoin initiation, most patients survived the initial trigger event (e.g., severe urinary tract infection, pneumonia) and demonstrated improvements in both short-term and long-term LC-FAOD manifestations. In patients with cardiomyopathy, stabilization or improvement from pretreatment levels was reported in left ventricular ejection fraction and left ventricular mass, in particular, all infants with cardiomyopathy showed improvement in cardiac function during triheptanoin therapy. Triheptanoin therapy was generally well tolerated. The study results are consistent with the existing positive benefit/risk profile of triheptanoin and reflect the effect of triheptanoin improving cardiac function in patients experiencing severe episodes of metabolic decompensation despite standard therapy." @default.
• W4223423433 created "2022-04-14" @default.
• W4223423433 creator A5008356363 @default.
• W4223423433 creator A5014572717 @default.
• W4223423433 creator A5025162900 @default.
• W4223423433 creator A5030996416 @default.
• W4223423433 creator A5066339144 @default.
• W4223423433 creator A5069743818 @default.
• W4223423433 creator A5070579431 @default.
• W4223423433 creator A5078786892 @default.
• W4223423433 creator A5084536564 @default.
• W4223423433 date "2022-06-01" @default.
• W4223423433 modified "2023-09-25" @default.
• W4223423433 title "Response to triheptanoin therapy in critically ill patients with LC-FAOD: Report of patients treated through an expanded access program" @default.
• W4223423433 cites W1547384695 @default.
• W4223423433 cites W1972881249 @default.
• W4223423433 cites W1986876315 @default.
• W4223423433 cites W2017907336 @default.
• W4223423433 cites W2034420020 @default.
• W4223423433 cites W2037365287 @default.
• W4223423433 cites W2060762124 @default.
• W4223423433 cites W2079844142 @default.
• W4223423433 cites W2092924634 @default.
• W4223423433 cites W2113593160 @default.
• W4223423433 cites W2121812481 @default.
• W4223423433 cites W2123942174 @default.
• W4223423433 cites W2159697997 @default.
• W4223423433 cites W2161597118 @default.
• W4223423433 cites W2518161914 @default.
• W4223423433 cites W2879079358 @default.
• W4223423433 cites W3042163005 @default.
• W4223423433 cites W3080376549 @default.
• W4223423433 cites W3083075215 @default.
• W4223423433 cites W3084423072 @default.
• W4223423433 cites W3092642428 @default.
• W4223423433 cites W3116080639 @default.
• W4223423433 cites W3128019292 @default.
• W4223423433 cites W3136173986 @default.
• W4223423433 cites W4230087065 @default.
• W4223423433 doi "https://doi.org/10.1016/j.ymgme.2022.04.001" @default.
• W4223423433 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35459555" @default.
• W4223423433 hasPublicationYear "2022" @default.
• W4223423433 type Work @default.
• W4223423433 citedByCount "4" @default.
• W4223423433 countsByYear W42234234332022 @default.
• W4223423433 countsByYear W42234234332023 @default.
• W4223423433 crossrefType "journal-article" @default.
• W4223423433 hasAuthorship W4223423433A5008356363 @default.
• W4223423433 hasAuthorship W4223423433A5014572717 @default.
• W4223423433 hasAuthorship W4223423433A5025162900 @default.
• W4223423433 hasAuthorship W4223423433A5030996416 @default.
• W4223423433 hasAuthorship W4223423433A5066339144 @default.
• W4223423433 hasAuthorship W4223423433A5069743818 @default.
• W4223423433 hasAuthorship W4223423433A5070579431 @default.
• W4223423433 hasAuthorship W4223423433A5078786892 @default.
• W4223423433 hasAuthorship W4223423433A5084536564 @default.
• W4223423433 hasBestOaLocation W42234234331 @default.
• W4223423433 hasConcept C126322002 @default.
• W4223423433 hasConcept C177713679 @default.
• W4223423433 hasConcept C2778198053 @default.
• W4223423433 hasConcept C2778797674 @default.
• W4223423433 hasConcept C2779134260 @default.
• W4223423433 hasConcept C2779306644 @default.
• W4223423433 hasConcept C2779379848 @default.
• W4223423433 hasConcept C2780668416 @default.
• W4223423433 hasConcept C71924100 @default.
• W4223423433 hasConceptScore W4223423433C126322002 @default.
• W4223423433 hasConceptScore W4223423433C177713679 @default.
• W4223423433 hasConceptScore W4223423433C2778198053 @default.
• W4223423433 hasConceptScore W4223423433C2778797674 @default.
• W4223423433 hasConceptScore W4223423433C2779134260 @default.
• W4223423433 hasConceptScore W4223423433C2779306644 @default.
• W4223423433 hasConceptScore W4223423433C2779379848 @default.
• W4223423433 hasConceptScore W4223423433C2780668416 @default.
• W4223423433 hasConceptScore W4223423433C71924100 @default.
• W4223423433 hasFunder F4320314124 @default.
• W4223423433 hasFunder F4320332161 @default.
• W4223423433 hasIssue "2" @default.
• W4223423433 hasLocation W42234234331 @default.
• W4223423433 hasLocation W42234234332 @default.
• W4223423433 hasOpenAccess W4223423433 @default.
• W4223423433 hasPrimaryLocation W42234234331 @default.
• W4223423433 hasRelatedWork W1963686979 @default.
• W4223423433 hasRelatedWork W1992894626 @default.
• W4223423433 hasRelatedWork W2008827134 @default.
• W4223423433 hasRelatedWork W2076974163 @default.
• W4223423433 hasRelatedWork W2092734860 @default.
• W4223423433 hasRelatedWork W2121421331 @default.
• W4223423433 hasRelatedWork W2121663374 @default.
• W4223423433 hasRelatedWork W2983693063 @default.
• W4223423433 hasRelatedWork W4322723037 @default.
• W4223423433 hasRelatedWork W4322723668 @default.
• W4223423433 hasVolume "136" @default.
• W4223423433 isParatext "false" @default.
• W4223423433 isRetracted "false" @default.
• W4223423433 workType "article" @default.